World Health Organization Addresses AI In Healthcare Bias, Outlines Guidance For Regulatory Compliance
Portfolio Pulse from Vandana Singh
The World Health Organization (WHO) has released a publication outlining regulatory considerations for the use of artificial intelligence (AI) in healthcare. The document emphasizes the importance of safety, efficacy, and rapid deployment of AI systems, and encourages dialogue among stakeholders. The U.S. is a key player in the AI in Healthcare Market, with companies such as Nvidia Corp, Intel Corporation, IBM, Alphabet Inc's Google, General Electric Co, Microsoft Corporation, Siemens Healthineers, Medtronic Plc, Micron Technology Inc, and Amazon Web Services leading the way.
October 19, 2023 | 3:08 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
General Electric, a significant player in the AI in Healthcare Market, could be affected by WHO's new regulatory guidelines.
General Electric, being a significant player in the AI in Healthcare Market, may see its operations and future projects impacted by the new regulatory guidelines from WHO.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70
NEUTRAL IMPACT
Alphabet Inc's Google, a key player in the AI in Healthcare Market, may be impacted by WHO's new regulatory considerations.
Google, being a key player in the AI in Healthcare Market, may see its operations and future projects impacted by the new regulatory guidelines from WHO.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70
NEUTRAL IMPACT
IBM, a major player in the AI in Healthcare Market, may be influenced by WHO's new regulatory considerations.
As a major player in the AI in Healthcare Market, IBM's operations and future projects may be influenced by the new regulatory considerations outlined by WHO.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70
NEUTRAL IMPACT
Intel, a significant player in the AI in Healthcare Market, could be affected by WHO's new regulatory guidelines.
Intel, being a significant player in the AI in Healthcare Market, may see its operations and future projects impacted by the new regulatory guidelines from WHO.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70
NEUTRAL IMPACT
Medtronic, a key player in the AI in Healthcare Market, may be impacted by WHO's new regulatory considerations.
Medtronic, being a key player in the AI in Healthcare Market, may see its operations and future projects impacted by the new regulatory guidelines from WHO.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70
NEUTRAL IMPACT
Microsoft, a major player in the AI in Healthcare Market, may be influenced by WHO's new regulatory considerations.
As a major player in the AI in Healthcare Market, Microsoft's operations and future projects may be influenced by the new regulatory considerations outlined by WHO.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70
NEUTRAL IMPACT
Micron Technology, a significant player in the AI in Healthcare Market, could be affected by WHO's new regulatory guidelines.
Micron Technology, being a significant player in the AI in Healthcare Market, may see its operations and future projects impacted by the new regulatory guidelines from WHO.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70
NEUTRAL IMPACT
Nvidia, a key player in the AI in Healthcare Market, may be impacted by WHO's new regulatory considerations.
As a major player in the AI in Healthcare Market, Nvidia's operations and future projects may be influenced by the new regulatory considerations outlined by WHO.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70